Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety

Autor:	Gert-Jan Braunstahl, J. C. C. M. in ’t Veen, Jermo J. van Toor, Jasper H Kappen, Sophie C van der Mark
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine Adult Male medicine.drug_class Eosinophilic asthma macromolecular substances Disease Monoclonal antibody Antibodies Monoclonal Humanized 03 medical and health sciences Young Adult 0302 clinical medicine Forced Expiratory Volume medicine Immunology and Allergy Humans 030212 general & internal medicine Anti-Asthmatic Agents Longitudinal Studies Pulmonary Eosinophilia Interleukin 5 Glucocorticoids Asthma Aged Retrospective Studies Response rate (survey) Aged 80 and over business.industry Middle Aged medicine.disease Hospitalization Treatment Outcome 030228 respiratory system Pediatrics Perinatology and Child Health Cohort Immunology Disease Progression Drug Therapy Combination Female business Mepolizumab medicine.drug
Zdroj:	The Journal of asthma : official journal of the Association for the Care of Asthma. 58(5)
ISSN:	1532-4303
Popis:	Introduction: Severe eosinophilic asthma is an incapacitating disease. Mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, proved to be effective as an add-on therapy in patients with ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4016a37edd1b711624f629c5b18d20e https://pubmed.ncbi.nlm.nih.gov/31999203 Zobrazit plný text záznamu